Endocrinology & Metabolism
Controlling lipid levels with less side effects possible with new drug
Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone receptor beta (THRβ).
Aug 6, 2024
0
26